Sensitizing to apoptosis - sharpening the medical sword

被引：21

作者：

Schuchmann, M ^{[1
]}

Galle, PR ^{[1
]}

机构：

[1] Univ Mainz, Dept Internal Med 1, D-55131 Mainz, Germany

来源：

关键词：

D O I：

10.1016/j.jhep.2003.11.022

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：335 / 336

页数：2

共 20 条

[1] Allgaier HP, 2003, HEPATOLOGY, V38, p760A
[2] Histone acetylation and cancer
Archer, SY
Hodin, RA
[J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 1999, 9 (02) : 171 - 174
[3] Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts
Bernhard, D
Skvortsov, S
Tinhofer, I
Hübl, H
Greil, R
Csordas, A
Kofler, R
[J]. CELL DEATH AND DIFFERENTIATION, 2001, 8 (10) : 1014 - 1021
[4] Cancer cell sensitization to Fas-mediated apoptosis by sodium butyrate
Bonnotte, B
Favre, N
Reveneau, S
Micheau, O
Droin, N
Garrido, C
Fontana, A
Chauffert, B
Solary, E
Martin, F
[J]. CELL DEATH AND DIFFERENTIATION, 1998, 5 (06) : 480 - 487
[5] NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma
Catley, L
Weisberg, E
Tai, YT
Atadja, P
Remiszewski, S
Hideshima, T
Mitsiades, N
Shringarpure, R
LeBlanc, R
Chauhan, D
Munshi, NC
Schlossman, R
Richardson, P
Griffin, J
Anderson, KC
[J]. BLOOD, 2003, 102 (07) : 2615 - 2622
[6] Glaser KB, 2002, MOL CANCER THER, V1, P759
[7] BCL-2 IS AN INNER MITOCHONDRIAL-MEMBRANE PROTEIN THAT BLOCKS PROGRAMMED CELL-DEATH
HOCKENBERY, D
NUNEZ, G
MILLIMAN, C
SCHREIBER, RD
KORSMEYER, SJ
[J]. NATURE, 1990, 348 (6299) : 334 - 336
[8] Inoue H, 2002, INT J MOL MED, V9, P521
[9] Kelly WK, 2003, CLIN CANCER RES, V9, P3578
[10] Kouraklis G., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P477, DOI 10.2174/1568011023353921